Directa Plus PLC Grant of US Patent
27 Junho 2019 - 03:01AM
RNS Non-Regulatory
TIDMDCTA
Directa Plus PLC
27 June 2019
27 June 2019
Directa Plus plc
("Directa Plus" or the "Company")
US Patent Grant
Directa Plus (AIM: DCTA), a leading producer and supplier of
graphene nanoplatelets based products for use in consumer and
industrial markets, is pleased to announce the grant of a key
patent, relating to the Company's unique manufacturing process, by
the United States Patent and Trademark Office.
The new US patent covers Directa Plus' unique process for
manufacturing graphene nanoplatelets using a water-based
exfoliation technology. The process is sustainable and
environmentally friendly as a result of using no chemicals,
solvents or surfactants and generating zero waste. The
manufacturing process allows the Company to engineer a wide range
of particle morphologies that can be tailored to the particular
requirements of end-user customers. In addition, the 100 per cent
production yield means that Directa Plus can manufacture products
in large volumes at attractive prices. This provides a significant
competitive advantage, enabling the Company to integrate
effectively and quickly with customers' large supply chains.
Commenting on the grant, Giulio Cesareo, Founder and CEO of
Directa Plus, said: "This grant represents a key development in
launching our products into the United States. The sustainable
nature of our production process, using no chemicals, is proving to
be an attractive point of difference in negotiations with large US
companies."
For further information please visit
http://www.directa-plus.com/ or contact:
Directa Plus plc +39 02 36714458
Giulio Cesareo, CEO
Marco Ferrari, CFO
Cantor Fitzgerald Europe (Nominated Adviser
and Joint Broker) +44 20 7894 7000
Rick Thompson, Philip Davies Will Goode
(Corporate Finance)
Caspar Shand Kydd (Sales)
N+1 Singer (Joint Broker) +44 20 7496 3069
Mark Taylor, Lauren Kettle
Tavistock (Financial PR and IR) +44 20 7920 3150
Simon Hudson, Barnaby Hayward, Edward
Lee
About Directa Plus
Our focus is principally on the two sectors in which we have
strong commercial advantage through developed and launched products
and a technological lead: environmental (based on our
Grafysorber(R) product) and textiles (based on our G+ products). In
addition, we will continue to pursue opportunities in elastomers
and composites (including tyres and asphalt), also using our G+
products. All our products are hypoallergenic, non-toxic and
sustainably produced.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRALLFVERRIRFIA
(END) Dow Jones Newswires
June 27, 2019 02:01 ET (06:01 GMT)
Directa Plus (LSE:DCTA)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Directa Plus (LSE:DCTA)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024